Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Neutralizing antibody response to SARS-CoV-2 variants, as determined by the MSD multiplex assay, following COVID-19 vaccination in cancer patients.
Journal: Vaccine: X
Published: July 28, 2026
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.
Journal: Science translational medicine
Published: July 30, 2025
A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial.
Journal: Nature medicine
Published: July 25, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.
Journal: Science (New York, N.Y.)
Published: May 15, 2025
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.
Journal: PLOS global public health
Published: June 02, 2024
SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials.
Journal: JAMA network open
Published: May 23, 2024
No immunological interference or concerns about safety when seasonal quadrivalent influenza vaccine is co-administered with a COVID-19 mRNA-1273 booster vaccine in adults: A randomized trial.
Journal: Human vaccines & immunotherapeutics
Published: March 21, 2024
COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 28, 2023
Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults: A Secondary Cross-Protocol Analysis of 4 Randomized Clinical Trials.
Journal: JAMA network open
Published: July 13, 2023
Stochastic interventional approach to assessing immune correlates of protection: Application to the COVE messenger RNA-1273 vaccine trial.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: July 13, 2023
Risk of COVID-19 after natural infection or vaccination.
Journal: EBioMedicine
Published: April 20, 2023
Last Updated: 09/26/2026